Although it is unknown whether SNPs directly alter the protein functionality of KEAP-1 to contribute to ROS imbalances, other associations between ROS and ovarian cancer likely exist, as evidenced by alterations in chemotherapeutic drug resistance, DNA damage, and tumor angiogenesis in these cells exposed to SNPs. This evidence concerns the gene KEAP1 and ovarian cancer.